SCHEMBL22328145

SCHEMBL22328145

Cc1ccc(S(=O)(=O)O)c(C(O)CO)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 1/20 0.35
GAA P10253 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
KMT2A Q03164 2/20 0.34
MEP1B Q16820 2/20 0.34
ALDH1A1 P00352 2/20 0.34
RECQL P46063 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
CASP6 P55212 1/20 0.34
ELAVL1 Q15717 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
HSD17B10 Q99714 2/20 0.33
RAPGEF4 Q8WZA2 1/20 0.33
CYP2C19 P33261 2/20 0.33
CYP1A2 P05177 1/20 0.33
MPL P40238 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15311992 0.87 PDE5A (0.37) PDE5AGAAL3MBTL1KMT2AMEP1B
SCHEMBL143706 0.87 PDE5A (0.37) PDE5AGAAL3MBTL1KMT2AMEP1B
Ethylene Glycol SCHEMBL7087133 0.85 ALDH1A1 (0.35) GAAL3MBTL1KMT2AMEP1BALDH1A1
SCHEMBL8470868 0.84 PDE5A (0.44) PDE5AGAAL3MBTL1KMT2AMEP1B
SCHEMBL26637678 0.83 PDE5A (0.49) PDE5AMEP1BPOLBMAPTRAPGEF4
Water SCHEMBL11279317 0.81 ALDH1A1 (0.36) GAAL3MBTL1KMT2AMEP1BALDH1A1
SCHEMBL8464278 0.81 LMNA (0.37) GAAL3MBTL1KMT2AMEP1BALDH1A1
SCHEMBL531432 0.79 LMNA (0.47) GAAL3MBTL1KMT2AALDH1A1RECQL
SCHEMBL9101570 0.79 LMNA (0.38) GAAL3MBTL1KMT2AMEP1BALDH1A1
SCHEMBL30716899 0.79 LMNA (0.38) GAAL3MBTL1KMT2AMEP1BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738023-B2 Method for producing 2-alkylcarbonylnaphtho[2,3-b]furan-4,9-dione-related substance, and said related substance SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738023-B2 Method for producing 2-alkylcarbonylnaphtho[2,3-b]furan-4,9-dione-related substance, and said related substance ADH1C, ADH5, ADH1A PDE5A 2741/4885GAA 2950/4885L3MBTL1 4840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.